Endpoint Health is a Precision-FirstTM therapeutics company
Endpoint Health is a Precision-FirstTM therapeutics company backed by top-tier Silicon Valley investors and founded by successful entrepreneurs who built and sold a previous healthcare company to Roche. Founded in 2018, we are on a mission to address urgent needs in immune-mediated diseases by delivering therapies that are personalized to each patient’s biology.
By combining data science, companion diagnostics and therapeutics, Endpoint Health is uniquely built for the new era of precision medicine.
Our vision is a world in which all patients get the best treatment possible for their unique biology and disease.